[Retracted] Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer

Table 4

CMap analysis identifies potential small molecular compounds.

CMap name	Mean		Enrichment	value	Specificity	Percent nonnull
Levomepromazine	0.760	4	0.896	0.0001	0.015	100
W-13	0.469	2	0.855	0.042	0.037	100
Diethylstilbestrol	0.686	6	0.850	0.00002	0	100
Cefoperazone	0.493	3	0.842	0.008	0.005	66
Vanoxerine	0.477	4	0.823	0.002	0.010	75
Terbutaline	0.303	4	0.774	0.005	0.006	50
PF-00875133-00	0.397	3	0.769	0.024	0.006	66
Kinetin	0.316	4	0.763	0.006	0	50
Fendiline	0.414	3	0.720	0.043	0.082	66
Vinburnine	0.348	4	0.718	0.013	0.053	50
Cefixime	-0.408	4	-0.705	0.016	0.005	50
Apigenin	-0.613	4	-0.706	0.015	0.103	75
Piroxicam	-0.524	4	-0.706	0.016	0.029	75
PNU-0230031	-0.305	8	-0.721	0.0001	0.005	50
Prestwick-682	-0.258	4	-0.727	0.011	0.021	50
Megestrol	-0.365	4	-0.728	0.011	0	75
Aminoglutethimide	-0.437	3	-0.760	0.028	0.024	66
Corticosterone	-0.394	4	-0.775	0.005	0	75
Fluorometholone	-0.627	4	-0.792	0.004	0	100
Withaferin A	-0.622	4	-0.804	0.009	0.090	100
Methacholine chloride	-0.719	3	-0.837	0.009	0.026	100
5224221	-0.647	2	-0.862	0.038	0.218	100
Y-27632	-0.773	2	-0.907	0.017	0.016	100
Pargyline	-0.75	4	-0.93	0.00002	0	100
Alcuronium chloride	-0.730	2	-0.936	0.009	0	100